1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Global Cell/Tissue Culture Supplies Industry

Global Cell/Tissue Culture Supplies Industry

  • October 2012
  • -
  • Global Industry Analysts
  • -
  • 506 pages

This report analyzes the worldwide markets for Cell/Tissue Culture Supplies in US$ Million by the following Product Segments: Media, Sera, and Reagents. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 92 companies including many key and niche players such as Affymetrix, Inc., AMRESCO, Inc., BD Biosciences, Cell Culture Technologies, LLC, Cell Essentials, Inc., EMD Millipore, Irvine Scientific, Life Technologies Corporation, Lonza Biologics Plc, Mediatech, Inc., Millipore Corporation, Medi-Cult A/S, MP Biomedicals, PerBio Science AB, PromoCell GmbH, Sera Laboratories International, Sigma-Aldrich Corporation, SAFC Biosciences, and Vitrolife AB. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Table Of Contents

Global Cell/Tissue Culture Supplies Industry



I. INTRODUCTION, METHODOLOGY and PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation and Reporting Level I-2
Quantitative Techniques and Analytics I-3
Product Definitions and Scope of Study I-3
Cell/Tissue Culture Media, Sera and Reagents I-3
Media I-3
Sera I-4
Reagents I-4


II. EXECUTIVE SUMMARY

1. MARKET DYNAMICS II-1
Outlook II-1
Biopharmaceutical Drugs Fuel Cell Culture Market II-1
Regenerative Medicine Kindles Exciting Prospects for Cell/
Tissue Culture Supplies Market II-2
Table 1: Global Market for Tissue Engineering and
Orthopedic/Spine Cell Therapy (2010): Percentage Share
Breakdown for Stryker, DuPuy, Medtronic, Zimmer, and Others
(includes corresponding Graph/Chart) II-3
Market Scenario II-3
Industrial vs. Academic II-3
Biotechnology Sector - Affected by Collapse of Capital Market II-3
Market Structure II-4

2. TRENDS AND ISSUES II-5
3D Technology to Put a New Spin on In Vitro Cell Analyses II-5
US Government's Policies to Boost Cell Culture Market II-5
Surging Demand for Cell Culture Products II-5
Stem Cells and Vaccines - Key Drivers II-6
Growing Acceptance for Hi-Veg Culture Media II-6
Fed-Batch Cultures - A Big Hit with Large-Scale Bioprocessors II-6
Changing Trend towards Serum-Free Media II-7
Proteomics and Pharmacokinetics to Drive Market Growth II-7
Bioresearch and Cell Culture in Protein Based Drug Development II-8
CHO, Hybridomas and Mabs Dominate Mammalian Cell Culture II-8
Sluggish Fetal Bovine Serum Market II-9
Specialty Media Demand on Rise II-9
Emerging Alternatives to Conventional Serum Supplemented Media II-9
Growth of Defined Media II-10
Regulations Prompt Change in Trends II-10
Media Optimization II-10
Cell-Line Engineering Vs. Cell Culture Media II-10
Other Trends II-10
Underlying Threat to Cell Culture Industry II-11
Manufacture-on-Demand: Gaining Momentum II-11
Move towards Contract Manufacturing II-11
Factors Impacting Growth II-11
Business Models Driving the Need for Contract Manufacturing II-12
Trends in Contract Manufacturing II-12
Target Sectors for Contract Manufacturers II-12

3. END-USE ANALYSIS II-13
End-Use Applications II-13
Cell Therapy II-13
Growing by Leaps and Bounds II-13
Cell Therapy Applications II-14
Key Factors Affecting the Cell Therapy Market II-14
Future Trends II-14
Related Market Sectors II-14
Progenitor Cell Therapy II-14
Stem Cell Therapy II-15
Other Related Technologies II-16
Somatic Cell Nuclear Transfer (SCNT) II-16
Tissue Engineering II-16
End Use Industries II-16

4. CELL/TISSUE CULTURE: PHYSIOLOGICAL OVERVIEW II-17
Introduction II-17
History II-17
Plant Culture: The Timeline II-17
Plant Cell and Tissue Culture (PCTC) II-21
Plant Tissue Culture Techniques and Applications II-22
Cell/Tissue Culture Media, Sera and Reagents II-25
Classical Media II-25
Specialty Media II-25
Serum II-25
Fetal Bovine Serum II-26
Serum-Free Media II-26
Cell Culture Reagents II-26
Role of Tissue Culture in the Growth of Cell Types II-26
Equipment II-26
Storage and Preservation II-27
Maintenance II-27
Growth Pattern II-27
Harvesting II-27
Suspension Cultures II-28
Adherent Cultures II-28
Mechanical II-28
Proteolytic Enzymes II-28
Standard Procedure for Detaching Adherent Cells II-28
Media and Growth Requirements II-28
Physiological Parameters II-28
Medium Requirements (Often Empirical) II-29
Feeding II-29
Safety Precautions II-29
Methods of Tissue Culture II-29
Preparation of Media II-29
Growth and Morphology II-30
Sub Culturing Adherent Cells II-30
Thawing Frozen Cells II-30
Freezing Cells II-30
3D Culture-Enabling Technologies II-30
Natural Scaffold Substrates II-30
Hydrogels II-30
Inert Non-Degradable Scaffolds II-31
Biodegradable Materials II-31
Cell Culture Contamination - A Looming Problem II-31
Classification II-31
Minor Annoyances II-32
Serious Problems II-32
Major Catastrophes II-32
Major Cell Culture Contaminants II-32
Chemical Contamination II-32
Types and Sources of Potential Chemical Contaminants II-32
Varied Sources of Chemical Contamination II-32
Media and Components II-33
Sera II-33
Water II-33
Storage Vessels II-34
Fluorescent Lights II-34
Endotoxins II-34
Incubators II-34
Biological Contamination II-35
Varied Sources of Biological Contamination II-35
Mycoplasmas II-35
Levels of Cell Culture Contamination Caused by Mycoplasma II-36
Airborne Particles and Aerosols II-36
Cross Contamination by Other Cell Cultures II-36
Consequences/Problems of Contamination II-36
Controlling Cell Culture Contamination II-37
Measures Aimed at Reducing Contamination Problems II-37

5. PRODUCT INNOVATIONS/INTRODUCTIONS II-38
PhoenixSongs Launches New Neural Cell Culture Media II-38
Selexis Unveils BalanCD CHO SLX A II-38
Irvine Launches BalanCDâ„¢ Cell Culture Media Product Series II-39
Thermo Fisher Launches HyCell CHO Cell-Culture Medium II-39
Corning Introduces Corning cellgro® II-40
StemCells Introduces 3 New Cell Culture Supplements II-40
SAFC® Launches New CHOZN® GS-/- Zinc Finger Nuclease-modified
Chinese Hamster Ovary Cell Line II-41
SAFC® Introduces First Product of ZFN-Modified Chinese Hamster
Ovary Cell Lines II-41
ORIGIO Unveils EmbryoGen® In Vitro Fertilization Medium II-42

6. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST - A PERSPECTIVE
BUILDER II-43
Charter Medical Unveils Pharmaceutical and Biotech Processing
Bio-Pak® Cell Culture Bags II-43
Vitrolife Unveils World's First Biorisk-Free Cytokines and
Growth Factors II-43
Millipore Launches EpiGro Epithelial Cells and Culture Media II-43
StemCells Unveils GS2-M Medium for Cell Culture II-44
StemCells Introduces GS1-Râ„¢ II-44
Kollodis BioSciences Introduces Cell-Culture Reagents II-44
The Automation Partnership Launches Automated Cell-Culture II-44
Novartis Receives Approval to Release New Vaccine II-45
Invitrogen Introduces GIBCO® OpTmizer TM T-cell Expansion SFM II-45
Novozymes Biopharma Rolls Out CellPrime in Partnership with
Millipore II-45
Invitrogen Launches Dynabeads® SSEA-4 II-46
Invitrogen Rolls Out KNOCKOUTâ„¢ SR XenoFree Media II-46
Lonza Develops One-Step Program II-46
Millipore Unveils ESGRO Completeâ„¢ PLUS Medium II-46
Millipore Introduces Hanging Millicell® Cell Culture Inserts II-46
SAFC Biosciences® Launches EX-CELLTM EBx® II-47
SAFC Biosciences® Rolls Out EX-Fusion and CHO Library II-47

7. RECENT INDUSTRY ACTIVITY II-48
EMD Millipore Takes Over Biochrom II-48
Kerry Ingredients and Flavours Establishes Cell Science
Laboratory at Customer Center of Excellence II-48
Merck KGaA Takes Over Beijing Skywing Technology II-48
Corning Takes Over Mediatech II-49
GE Healthcare Takes Over PAA II-49
Compass Expands Partnership with PanGen II-49
Miltenyi Enters into Partnership with TeutoCell II-50
SAFC® Enters into Licensing Deal with Agilent II-50
Life Technologies Obtains FDA Clearance to Launch StemPro® MSC
SFM II-51
Transparent Inks Agreement with Molecular Response II-51
Wockhardt Inks Agreement with Sheffield Bio-Science II-52

8. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER II-53
PX'Therapeutics to Establish cGMP Production Unit II-53
BioTime Asia Signs Marketing Agreement with Shanghai Genext
Medical Technology II-53
EHSI Acquires Synthecon's Bioreactor II-53
Essential Pharmaceuticals Inks Agreement with Lifeblood Medical II-54
Vitro Revises Agreement with HemoGenix II-54
International Stem Cell Corporation Enters into Agreement with
Insight Bioventures India to Establish ISCO India II-54
GCS Inks Agreement with VWR II-55
Irvine Scientific Opens New Industrial Cell Culture Media
Production Unit in Tokyo II-56
BioTime to Introduce 7 Novel Human Embryonic Progenitor Cell
Lines and 7 New Culture Media II-56
Lifeline Cell Technology Enters into Distribution Agreement
with Sristi Biosciences II-57
Reinnervate Obtains Investment to Realize Commercial Viability
of Alvetex® 3D Cell Culture Platform II-57
American CryoStem Obtains Patent for 'Cell Culture Media,
Kits, and Methods of Use' II-57
Akron Biotechnology Merges with AppliChem II-58
ChanTest Takes Over Applied Cell Sciences II-58
Millipore Takes Over Guava Technologies II-58
Millipore Acquires EpiTagâ„¢ Technology from Epitome Biosystems II-59
MediCult's BlastAssist® Culture Media Obtains FDA Approval II-59
Capsant Signs Commercialization Agreement with VistaGen II-59

9. FOCUS ON SELECT PLAYERS II-60
Affymetrix, Inc. (US) II-60
AMRESCO, Inc. (US) II-60
BD Biosciences (US) II-60
Cell Culture Technologies, LLC (Switzerland) II-61
Cell Essentials, Inc. (US) II-61
Corning, Inc. (US) II-61
EMD Millipore (US) II-62
Irvine Scientific, Inc. (US) II-62
Life Technologies Corporation (US) II-62
Lonza Biologics Plc (UK) II-63
MP Biomedicals LLC (US) II-63
ORIGIO a/s (Denmark) II-63
PromoCell GmbH (Germany) II-63
Sera Laboratories International Ltd (UK) II-64
Sigma-Aldrich Corporation (US) II-64
SAFC Biosciences, Inc. (US) II-65
Thermo Fisher Scientific, Inc. (US) II-65
Vitrolife AB (Sweden) II-65

10. GLOBAL MARKET PERSPECTIVE II-66
Table 2: World Recent Past, Current and Future Analysis for
Cell/Tissue Culture Supplies by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) II-66

Table 3: World Historic Review for Cell/Tissue Culture
Supplies by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan) and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-67

Table 4: World 15-Year Perspective for Cell/Tissue Culture
Supplies by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan) and Latin America Markets for Years 2004, 2011 and 2018
(includes corresponding Graph/Chart) II-68
Cell/Tissue Culture Supplies Market by Product Segment II-69
Table 5: World Recent Past, Current and Future Analysis for
Media Cell/Tissue Culture Supplies by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) II-69

Table 6: World Historic Review for Media Cell/Tissue Culture
Supplies by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan) and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-70

Table 7: World 15-Year Perspective for Media Cell/ Tissue
Culture Supplies by Geographic Region - Percentage Breakdown
of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) and Latin America Markets for Years 2004, 2011
and 2018 (includes corresponding Graph/Chart) II-71

Table 8: World Recent Past, Current and Future Analysis for Sera
Cell/Tissue Culture Supplies by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) II-72

Table 9: World Historic Review for Sera Cell/Tissue Culture
Supplies by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan) and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-73

Table 10: World 15-Year Perspective for Sera Cell/ Tissue
Culture Supplies by Geographic Region - Percentage Breakdown
of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) and Latin America Markets for Years 2004, 2011 and
2018 (includes corresponding Graph/Chart) II-74

Table 11: World Recent Past, Current and Future Analysis for
Reagent Cell/Tissue Culture Supplies by Geographic Region -
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) II-75

Table 12: World Historic Review for Reagent Cell/ Tissue
Culture Supplies by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan) and Latin American
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-76

Table 13: World 15-Year Perspective for Reagent Cell/Tissue
Culture Supplies by Geographic Region - Percentage Breakdown
of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) and Latin America Markets for Years 2004, 2011 and
2018 (includes corresponding Graph/Chart) II-77


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Current and Future Analysis III-1
Cell and Tissue Culture Market III-1
A Brief Insight III-1
Market Trends III-2
Trend Towards Serum-Free Media III-2
Liquid and Powdered Media Account for Major Share III-2
Table 14: Leading Players in the US Cell Culture Media
Market (2010): Percentage Breakdown of Sales for
Sigma-Aldrich, Hyclone, Lonza Biologics, and Others
(includes corresponding Graph/Chart) III-2
Fetal Bovine Serum - On a Decline III-3
Rise in Cell Culture Equipment Demand Leads to Innovation III-3
Market for Stem Cell Research III-3
End-Use Analysis III-4
Table 15: US Market for Cell Culture Reagents (2010):
Percentage Breakdown by End-Use for Academic, Industrial,
and Non-Academic (includes corresponding Graph/Chart) III-4
Factors Influencing Tissue and Cell Culture Media Market III-4
Regulatory Controls III-4
Guidelines Governing Use of Cell/Tissue Culture Reagents III-5
MSDS and Hazardous Information III-5
Toxic Substances Control Act III-5
Regulatory Environment III-5
Major FDA Regulations III-6
Export/Import Stats - A Historic Perspective III-6
Table 16: US Imports of Preparation Culture Media for the
Development of Microorganisms and Plant/Human/Animal Cells
(2009): Percentage Breakdown of Import Value by Country
(includes corresponding Graph/Chart) III-6

Table 17: US Exports of Preparation Culture Media for the
Development of Microorganisms and Plant/Human/Animal Cells
(2009): Percentage Breakdown of Export Value by Country
(includes corresponding Graph/Chart) III-7
Strategic Corporate Developments III-7
Product Launches III-10
Key Players III-13
B.Market Analytics III-18
Table 18: US Recent Past, Current and Future Analysis for
Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-18

Table 19: US Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-19

Table 20: US 15-Year Perspective for Cell/ Tissue Culture
Supplies by Product Segment - Percentage Breakdown of Dollar
Sales for Media, Sera, and Reagents Markets for Years 2004,
2011 and 2018 (includes corresponding Graph/Chart) III-20

2. CANADA III-21
A.Market Analysis III-21
Current and Future Analysis III-21
Biotechnology Industry III-21
B.Market Analytics III-22
Table 21: Canadian Recent Past, Current and Future Analysis
for Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-22

Table 22: Canadian Historic Review for Cell/ Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-23

Table 23: Canadian 15-Year Perspective for Cell/Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2004, 2011 and 2018 (includes corresponding Graph/Chart) III-24

3. JAPAN III-25
A.Market Analysis III-25
Current and Future Analysis III-25
Strategic Corporate Development III-25
B.Market Analytics III-26
Table 24: Japanese Recent Past, Current and Future Analysis
for Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-26

Table 25: Japanese Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-27

Table 26: Japanese 15-Year Perspective for Cell/Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2004, 2011 and 2018 (includes corresponding Graph/Chart) III-28

4. EUROPE III-29
A.Market Analysis III-29
Current and Future Analysis III-29
Market Overview III-29
B.Market Analytics III-30
Table 27: European Recent Past, Current and Future Analysis
for Cell/Tissue Culture Supplies by Geographic Region -
France, Germany, Italy, UK and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-30

Table 28: European Historic Review for Cell/Tissue Culture
Supplies by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2004 through
2009 (includes corresponding Graph/Chart) III-31

Table 29: European 15-Year Perspective for Cell/Tissue
Culture Supplies by Geographic Region - Percentage Breakdown
of Dollar Sales for France, Germany, Italy, UK and Rest of
Europe Markets for Years 2004, 2011 and 2018 (includes
corresponding Graph/Chart) III-32

Table 30: European Recent Past, Current and Future Analysis
for Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-33

Table 31: European Historic Review for Cell/ Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-34

Table 32: European 15-Year Perspective for Cell/Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2004, 2011 and 2018 (includes corresponding Graph/Chart) III-35

4a. FRANCE III-36
A.Market Analysis III-36
Current and Future Analysis III-36
B.Market Analytics III-36
Table 33: French Recent Past, Current and Future Analysis for
Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-36

Table 34: French Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-37

Table 35: French 15-Year Perspective for Cell/ Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2004, 2011 and 2018 (includes corresponding Graph/Chart) III-38

4b. GERMANY III-39
A.Market Analysis III-39
Current and Future Analysis III-39
Biotech Research Scenario III-39
Table 36: German Biotech Market - A Historic Perspective
(2009): Percentage Breakdown by Application Area for
Environment, Human Health Care, Chemical industry, Food,
Agriculture, Energy, and Others (includes corresponding
Graph/Chart) III-40
Strategic Corporate Developments III-40
PromoCell GmbH - A Key Player III-41
B.Market Analytics III-42
Table 37: German Recent Past, Current and Future Analysis for
Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-42

Table 38: German Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-43

Table 39: German 15-Year Perspective for Cell/Tissue Culture
Supplies by Product Segment - Percentage Breakdown of Dollar
Sales for Media, Sera, and Reagents Markets for Years 2004,
2011 and 2018 (includes corresponding Graph/Chart) III-44

4c. ITALY III-45
A.Market Analysis III-45
Current and Future Analysis III-45
B.Market Analytics III-45
Table 40: Italian Recent Past, Current and Future Analysis for
Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-45

Table 41: Italian Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-46

Table 42: Italian 15-Year Perspective for Cell/ Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2004, 2011 and 2018 (includes corresponding Graph/Chart) III-47

4d. THE UNITED KINGDOM III-48
A.Market Analysis III-48
Current and Future Analysis III-48
Biotechnology Industry - A Brief Insight III-48
Regulatory Issues III-49
HFE Act Guidelines III-49
Ethical Issues III-49
Key Players III-50
B.Market Analytics III-51
Table 43: UK Recent Past, Current and Future Analysis for
Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-51

Table 44: UK Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-52

Table 45: UK 15-Year Perspective for Cell/ Tissue Culture
Supplies by Product Segment - Percentage Breakdown of Dollar
Sales for Media, Sera, and Reagents Markets for Years 2004,
2011 and 2018 (includes corresponding Graph/Chart) III-53

4e. REST OF EUROPE III-54
A.Market Analysis III-54
Current and Future Analysis III-54
Scenario in other European Countries III-54
Strategic Coprorate Development III-54
Product Launches III-55
Key Players III-56
B.Market Analytics III-57
Table 46: Rest of Europe Recent Past, Current and Future
Analysis for Cell/Tissue Culture Supplies by Product Segment -
Media, Sera, and Reagents Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-57

Table 47: Rest of Europe Historic Review for Cell/ Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-58

Table 48: Rest of Europe 15-Year Perspective for Cell/Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera and Reagent Markets for
Years 2004, 2011 and 2018 (includes corresponding Graph/Chart) III-59

5. ASIA-PACIFIC III-60
A.Market Analysis III-60
Current and Future Analysis III-60
Rise of Cell Culture in Asia III-60
Overview of Select Markets III-60
Australia III-60
China III-60
India III-61
Cell Culture Market Constituents III-61
Taiwan III-61
Strategic Corporate Developments III-62
B.Market Analytics III-63
Table 49: Asia-Pacific Recent Past, Current and Future
Analysis for Cell/Tissue Culture Supplies by Product Segment -
Media, Sera, and Reagents Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-63

Table 50: Asia-Pacific Historic Review for Cell/ Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-64

Table 51: Asia-Pacific 15-Year Perspective for Cell/Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera and Reagent Markets for
Years 2004, 2011 and 2018 (includes corresponding Graph/Chart) III-65

6. LATIN AMERICA III-66
A.Market Analysis III-66
Current and Future Analysis III-66
Brazilian Biotech Industry - An Overview III-66
B.Market Analytics III-67
Table 52: Latin American Recent Past, Current and Future
Analysis for Cell/Tissue Culture Supplies by Product Segment -
Media, Sera, and Reagents Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-67

Table 53: Latin American Historic Review for Cell/ Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-68

Table 54: Latin American 15-Year Perspective for Cell/Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera and Reagent Markets for
Years 2004, 2011 and 2018 (includes corresponding Graph/Chart) III-69


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 92 (including Divisions/Subsidiaries - 104)

The United States (58)
Canada (3)
Japan (3)
Europe (33)
- France (2)
- Germany (9)
- The United Kingdom (12)
- Spain (1)
- Rest of Europe (9)
Asia-Pacific (Excluding Japan) (6)
Latin America (1)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

  • $ 6 995
  • Industry report
  • August 2016
  • by GBI Research

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation Summary Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable ...

The Global Market for Stem Cells

The Global Market for Stem Cells

  • $ 6 650
  • Industry report
  • May 2016
  • by BCC Research

This BCC Research report provides implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and important ...

Stem Cell Banking Market by Bank Type, Service, Application, Region - Forecast to 2021

Stem Cell Banking Market by Bank Type, Service, Application, Region - Forecast to 2021

  • $ 5 650
  • Industry report
  • July 2016
  • by MarketsandMarkets

The global stem cell banking market is expected to reach USD 3.96 billion by 2021 from USD 1.58 billion in 2016, at a CAGR of 20.2% from 2016 to 2021. The storage services segment is expected to contribute ...

Trends In Gene Therapy

July 2016 $ 5 000

ref:plp2012

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.